Terms: = Lung cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Prognosis
79 results:
1. TMEM158 functions as an oncogene and promotes lung adenocarcinoma progression through the PI3K/AKT pathway via interaction with TWIST1.
Xu T; Yin F; Shi K
Exp Cell Res; 2024 Apr; 437(1):114010. PubMed ID: 38508329
[TBL] [Abstract] [Full Text] [Related]
2. STMN1 Promotes Tumor Metastasis in Non-small Cell lung cancer Through Microtubule-dependent And Nonmicrotubule-dependent Pathways.
Zeng L; Lyu X; Yuan J; Chen Y; Wen H; Zhang L; Shi J; Liu B; Li W; Yang S
Int J Biol Sci; 2024; 20(4):1509-1527. PubMed ID: 38385074
[TBL] [Abstract] [Full Text] [Related]
3. A Nomogram and Risk Classification System Predicting the prognosis of Patients with De Novo Metastatic Breast cancer Undergoing Immediate Breast Reconstruction: A Surveillance, Epidemiology, and End Results Population-Based Study.
Zhao J; Bian S; Di X; Xiao C
Curr Oncol; 2023 Dec; 31(1):115-131. PubMed ID: 38248093
[TBL] [Abstract] [Full Text] [Related]
4. DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway.
Mi K; Zeng L; Chen Y; Ning J; Zhang S; Zhao P; Yang S
Cell Signal; 2024 Jan; 113():110962. PubMed ID: 37931691
[TBL] [Abstract] [Full Text] [Related]
5. FTO facilitates cancer metastasis by modifying the m
Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
[TBL] [Abstract] [Full Text] [Related]
6. Downregulation of AHNAK2 inhibits cell cycle of lung adenocarcinoma cells by interacting with RUVBL1.
Li X; Li H; Shao MM; Miao J; Fu Y; Hu B
Thorac Cancer; 2023 Aug; 14(22):2093-2104. PubMed ID: 37349884
[TBL] [Abstract] [Full Text] [Related]
7. PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration.
Zhang J; Ma Q; Yu Q; Xiao F; Zhang Z; Feng H; Liang C
Biol Direct; 2023 Jun; 18(1):33. PubMed ID: 37337223
[TBL] [Abstract] [Full Text] [Related]
8. FATP2 regulates non-small cell lung cancer by mediating lipid metabolism through ACSL1.
Chen Y; Zhao Y; Deng Y; Yang Y; Xu L; Fu J
Tissue Cell; 2023 Jun; 82():102105. PubMed ID: 37172427
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic association of immunoproteasome expression in solid tumours is governed by the immediate immune environment.
Kumar R; Dhaka B; Sahoo S; Jolly MK; Sabarinathan R
Mol Oncol; 2023 Jun; 17(6):1041-1059. PubMed ID: 37097039
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
Wattanathamsan O; Chantaravisoot N; Wongkongkathep P; Kungsukool S; Chetprayoon P; Chanvorachote P; Vinayanuwattikun C; Pongrakhananon V
J Biomed Sci; 2023 Jan; 30(1):4. PubMed ID: 36639650
[TBL] [Abstract] [Full Text] [Related]
11. Sestrin2 mediates FOXM1 expression to block the EMT process in non-small cell lung cancer through the AMPK/YAP pathway.
Wang YL; Wang Q; Li H; Wang CC; Ma YL; Han Z
Neoplasma; 2023 Feb; 70(1):46-57. PubMed ID: 36620877
[TBL] [Abstract] [Full Text] [Related]
12. Usefulness of serum S100A4 and positron-emission tomography on lung cancer accompanied by interstitial pneumonia.
Kagimoto A; Tsutani Y; Kushitani K; Kambara T; Mimae T; Miyata Y; Takeshima Y; Okada M
Thorac Cancer; 2023 Feb; 14(4):381-388. PubMed ID: 36537055
[TBL] [Abstract] [Full Text] [Related]
13. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
Dou X; Wang Z; Lu W; Miao L; Zhao Y
BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
[TBL] [Abstract] [Full Text] [Related]
14. RNF2 mediates pulmonary fibroblasts activation and proliferation by regulating mTOR and p16-CDK4-Rb1 signaling pathway.
Pan L; Hu Y; Qian C; Yao Y; Wang S; Shi W; Xu T
Inflamm Res; 2022 Nov; 71(10-11):1283-1303. PubMed ID: 35933565
[TBL] [Abstract] [Full Text] [Related]
15. Discoidin domain receptor 1 promotes lung adenocarcinoma migration via the AKT/snail signaling axis.
Zhu J; Cheng H; Wang L; Xu W; Wang J; Han Q; Lee JH; Du L; Lyu J
Mol Biol Rep; 2022 Aug; 49(8):7275-7286. PubMed ID: 35562515
[TBL] [Abstract] [Full Text] [Related]
16. E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway.
Liang M; Wang L; Sun Z; Chen X; Wang H; Qin L; Zhao W; Geng B
Cell Commun Signal; 2022 May; 20(1):62. PubMed ID: 35534896
[TBL] [Abstract] [Full Text] [Related]
17. A novel tRNA-derived fragment AS-tDR-007333 promotes the malignancy of NSCLC via the HSPB1/MED29 and ELK4/MED29 axes.
Yang W; Gao K; Qian Y; Huang Y; Xiang Q; Chen C; Chen Q; Wang Y; Fang F; He Q; Chen S; Xiong J; Chen Y; Xie N; Zheng D; Zhai R
J Hematol Oncol; 2022 May; 15(1):53. PubMed ID: 35526007
[TBL] [Abstract] [Full Text] [Related]
18. Claudin-10 overexpression suppresses human clear cell renal cell carcinoma growth and metastasis by regulating ATP5O and causing mitochondrial dysfunction.
Yang W; Zhang K; Zhang Z; Zhou J; Li L; Xu Y; Qiu J; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(6):2329-2344. PubMed ID: 35414767
[TBL] [Abstract] [Full Text] [Related]
19. Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia.
Hashimoto S; Iwata H; Hattori Y; Nakajima K; Nomura K; Hayashi K; Toshito T; Yamamori E; Akita K; Mizoe JE; Ogino H; Shibamoto Y
Radiat Oncol; 2022 Mar; 17(1):56. PubMed ID: 35313905
[TBL] [Abstract] [Full Text] [Related]
20. TTPAL promotes gastric tumorigenesis by directly targeting NNMT to activate PI3K/AKT signaling.
Liu W; Gou H; Wang X; Li X; Hu X; Su H; Li S; Yu J
Oncogene; 2021 Dec; 40(49):6666-6679. PubMed ID: 34642500
[TBL] [Abstract] [Full Text] [Related]
[Next]
